Multidrug‐resistant Acinetobacter: a threat to the antibiotic era
- 7 July 2006
- journal article
- Published by Wiley in Internal Medicine Journal
- Vol. 36 (8), 479-482
- https://doi.org/10.1111/j.1445-5994.2006.01130.x
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Inter-country transfer of Gram-negative organisms carrying the VIM-4 and OXA-58 carbapenem-hydrolysing enzymesJournal of Antimicrobial Chemotherapy, 2006
- Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse eventsClinical Microbiology & Infection, 2005
- Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibioticClinical Microbiology & Infection, 2005
- Evaluation of colistin as an agent against multi-resistant Gram-negative bacteriaInternational Journal of Antimicrobial Agents, 2004
- Antimicrobial resistance of Acinetobacter spp. in EuropeClinical Microbiology & Infection, 2004
- Considerations in Control and Treatment of Nosocomial Infections Due to Multidrug‐ResistantAcinetobacter baumanniiClinical Infectious Diseases, 2003
- Survival of Acinetobacter baumannii on bed rails during an outbreak and during sporadic casesJournal of Hospital Infection, 1999
- Outbreak of gentamicin-resistant Acinetobacter baumanii in an intensive care unit: clinical, epidemiological and microbiological featuresPathology, 1996
- Investigation of a Multiyear Multiple Critical Care Unit Outbreak Due to Relatively Drug-Sensitive Acinetobacter baumannii: Risk Factors and Attributable MortalityThe Journal of Infectious Diseases, 1996
- Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactamThe Lancet, 1994